Get your BioDrugs paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.2
Authored by Sumalatha Gangadhar | Published on 30 July, 2026
Submitting to BioDrugs goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the BioDrugs guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to BioDrugs. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the BioDrugs journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the BioDrugs guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the BioDrugs guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through Editorial Manager.
| Element | BioDrugs requirement |
|---|---|
| Abstract | 150 to 250 words (up to 450 words for systematic reviews and original research if needed for compliance with reporting guidelines). Structure depends on article type: unstructured for narrative reviews, structured for original research (following CONSORT, PRISMA, or STROBE guidelines) |
| Main text | Leading Article: up to 4000 words; Review Article: up to 8000 words; Current Opinion: up to 3000 words; Systematic Review: up to 10,000 words; Original Research: up to 6000 words; Letter to the Editor: up to 1000 words; Editorial/Commentary: up to 1500 words (excludes abstract, references, figure legends, and table captions) |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| References | Vancouver style (numbered in square brackets, listed consecutively) |
| Peer review | Single-blind (reviewer identities confidential, author identities known to reviewers) |
| Submission | www.editorialmanager.com/bdra |
| Keywords | Not required |
Read the BioDrugs guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to BioDrugs in under a page.
Skim two or three recent BioDrugs papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the BioDrugs journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the BioDrugs guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through Editorial Manager.